Gastrointestinal Cancer

Top Story

Risk protocol identifies patients with cancer not allergic to carboplatin, oxaliplatin

August 28, 2015

Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the chemotherapy drugs after skin prick tests, according to retrospective study results.

The risk-stratification protocol appeared to safely identify patients without allergic reaction to the drugs, allowing them to return to an outpatient setting for further treatment without desensitization.

CMS votes unanimously to maintain Medicare's reimbursement rate for Cologuard CRC screening test

August 27, 2015
The CMS Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously (11-0) to maintain Medicare’s current reimbursement rate of $492.72 for the…
Jennifer Permuth-Wey, PhD In the Journals

MicroRNA panel may help identify malignant pancreatic lesions

August 27, 2015
A microRNA panel that assesses blood plasma levels may distinguish individuals with intraductal papillary mucinous neoplasms in the pancreas from healthy individuals…
In the Journals

Obesity in early adulthood increases risk for HCC

August 26, 2015
In a new study, researchers found that people who were obese in early adulthood had an increased risk for developing hepatocellular carcinoma later on, according to…
CME
Updates in Immunotherapy – Philadelphia 2015

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »
Meeting News Coverage Video
VIDEO: HPV vaccination trial provides 'reassuring' data on multisite protection

VIDEO: HPV vaccination trial provides 'reassuring' data on multisite protection

April 28, 2015
PHILADELPHIA — Barbara Burtness, MD, professor of medical oncology at Yale Cancer Center and a HemOnc
More »
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
In the Journals

Risk protocol identifies patients with cancer not allergic to carboplatin, oxaliplatin

August 28, 2015
Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the…

CMS votes unanimously to maintain Medicare's reimbursement rate for Cologuard CRC screening test

August 27, 2015
The CMS Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously (11-0) to maintain Medicare’s current reimbursement rate of…
Jennifer Permuth-Wey, PhD In the Journals

MicroRNA panel may help identify malignant pancreatic lesions

August 27, 2015
A microRNA panel that assesses blood plasma levels may distinguish individuals with intraductal papillary mucinous neoplasms in the pancreas from…
In the Journals

Obesity in early adulthood increases risk for HCC

August 26, 2015
In a new study, researchers found that people who were obese in early adulthood had an increased risk for developing hepatocellular carcinoma later…
In the Journals

New blood test shows promise for screening of CRC, precancerous lesions

August 26, 2015
Surface enhanced Raman spectroscopy analysis of blood plasma was shown to detect colorectal cancer and adenomatous polyps with high accuracy…
In the Journals

Long-term use of aspirin, NSAIDs may reduce colorectal cancer risk

August 26, 2015
The continuous, long-term use of low-dose aspirin and NSAIDs appeared to reduce the risk for colorectal cancer, according to results of a…
Top Takeaways from ASCO: Gastrointestinal cancer

Top Takeaways from ASCO: Gastrointestinal cancer

August 24, 2015
CHICAGO — Encouraging data on using immunotherapy and a new chemotherapy combination to treat gastrointestinal cancers were revealed at the…
Lorenzo Cohen, PhD

Stress and cancer: Mindfulness is pivotal component to improve outcomes

August 24, 2015
Stress hormones are released when the body responds to physical, mental or emotional pressures.These stress hormones — such as epinephrine and…
FDA News

FDA grants orphan drug designation to varlitinib for cholangiocarcinoma

August 20, 2015
The FDA granted orphan drug designation to varlitinib — an oral, novel pan-HER inhibitor — for the treatment of patients with…
In the Journals

Vemurafenib shows promise for BRAFV600 -mutated nonmelanoma cancers

August 20, 2015
The BRAF V600 oncogene appeared targetable in certain nonmelanoma cancers, according to the results of a phase 2 study.Further, vemurafenib…
More Headlines »
morganatic-roan